Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 1, 2016
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria DonorsY Le Meur, F Aulagnon, D Bertrand, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 31, 2016
Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infectionsT Crepin, E Gaiffe, C Courivaud, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2007
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroidsM Büchler, S Caillard, S Barbier, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept studyY Lebranchu, A Thierry, O Toupance, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.Clinical Pharmacology and Therapeutics|April 16, 2010
Optimization of initial tacrolimus dose using pharmacogenetic testingE Thervet, M A Loriot, S Barbier, et al.Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2016
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized StudyP Gatault, N Kamar, M Büchler, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2015
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrationsN Pallet, A-S Jannot, M El Bahri, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2016
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic ScreeningC Damon, M Luck, L Toullec, et al.Pageof 2